EWS, but Not EWS-FLI-1, Is Associated with Both TFIID and RNA Polymerase II: Interactions between Two Members of the TET Family, EWS and hTAFII68, and Subunits of TFIID and RNA Polymerase II Complexes
- 1 March 1998
- journal article
- Published by Taylor & Francis in Molecular and Cellular Biology
- Vol. 18 (3) , 1489-1497
- https://doi.org/10.1128/mcb.18.3.1489
Abstract
The t(11;22) chromosomal translocation specifically linked to Ewing sarcoma and primitive neuroectodermal tumor results in a chimeric molecule fusing the amino-terminus-encoding region of theEWS gene to the carboxyl-terminal DNA-binding domain encoded by the FLI-1 gene. As the function of the protein encoded by the EWS gene remains unknown, we investigated the putative role of EWS in RNA polymerase II (Pol II) transcription by comparing its activity with that of its structural homolog, hTAFII68. We demonstrate that a portion of EWS is able to associate with the basal transcription factor TFIID, which is composed of the TATA-binding protein (TBP) and TBP-associated factors (TAFIIs). In vitro binding studies revealed that both EWS and hTAFII68 interact with the same TFIID subunits, suggesting that the presence of EWS and that of hTAFII68 in the same TFIID complex may be mutually exclusive. Moreover, EWS is not exclusively associated with TFIID but, similarly to hTAFII68, is also associated with the Pol II complex. The subunits of Pol II that interact with EWS and hTAFII68 have been identified, confirming the association with the polymerase. In contrast to EWS, the tumorigenic EWS–FLI-1 fusion protein is not associated with either TFIID or Pol II in Ewing cell nuclear extracts. These observations suggest that EWS and EWS–FLI-1 may play different roles in Pol II transcription.Keywords
This publication has 44 references indexed in Scilit:
- Production and Characterization of Mouse Monoclonal Antibodies to Wild-Type and Oncogenic FLI-1 ProteinsHybridoma, 1997
- A new member of the ETS family fused to EWS in Ewing tumorsOncogene, 1997
- Transcription factors as drug targets in cancerEuropean Journal Of Cancer, 1996
- A Novel Chimera Gene betweenEWSandE1A-F, Encoding the Adenovirus E1A Enhancer-Binding Protein, in Extraosseous Ewing's SarcomaBiochemical and Biophysical Research Communications, 1996
- Indirect and Direct Disruption of Transcriptional Regulation in Cancer: E2F and AML-1Critical Reviews™ in Eukaryotic Gene Expression, 1995
- Transcriptional elongation by RNA polymerase II is stimulated by transactivatorsCell, 1994
- Fusion of the dominant negative transcription regulator CHOP with a novel gene FUS by translocation t(12;16) in malignant liposarcomaNature Genetics, 1993
- Fusion of CHOP to a novel RNA-binding protein in human myxoid liposarcomaNature, 1993
- Oncogenic conversion by regulatory changes in transcription factorsCell, 1991
- Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferaseGene, 1988